Recalls & Warnings September 18, 2012 Maker of Noni, Nopal, Blood Sugar and Cholesterol Supplements Warned For Drug Claims, Misbranding, and Manufacturing Violations On August 27, 2012, the FDA issued a warning letter to Naturavit, Inc
By using AI to analyze more than 400,000 Reddit posts, researchers at Penns School of Engineering and Applied Science have identified patient-reported symptoms associated with GLP-1s, the popular weight-loss and diabetes drugs semaglutide and tirzepatide, that may not be fully captured in clinical trials or regulatory documents
From first-time clients to seasoned health and beauty aficionados, we are committed to providing you with the best possible experience every single time
Meal timing matters as much as total calories
A recent systematic review identified 33 registered trials looking at GLP-1s for SUDs, predominantly for alcohol and nicotine, but with growing interest in opioid and stimulant SUDs